Morten Hansen
Morten Hansen
Head of Flow Cytometry, National Center for Cancer Immune Therapy at Herlev Hospital
Email confirmado em regionh.dk
Título
Citado por
Citado por
Ano
The effect of short-chain fatty acids on human monocyte-derived dendritic cells
C Nastasi, M Candela, CM Bonefeld, C Geisler, M Hansen, T Krejsgaard, ...
Scientific reports 5 (1), 1-10, 2015
1952015
Predictors of responses to immune checkpoint blockade in advanced melanoma
N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, ...
Nature communications 8 (1), 1-13, 2017
1252017
The role of dendritic cells in cancer
M Hansen, MH Andersen
Seminars in immunopathology 39 (3), 307-316, 2017
522017
In-chip fabrication of free-form 3D constructs for directed cell migration analysis
MH Olsen, GM Hjortø, M Hansen, Ö Met, IM Svane, NB Larsen
Lab on a Chip 13 (24), 4800-4809, 2013
502013
Injection molded chips with integrated conducting polymer electrodes for electroporation of cells
KØ Andresen, M Hansen, M Matschuk, ST Jepsen, HS Sørensen, P Utko, ...
Journal of Micromechanics and Microengineering 20, 055010, 2010
472010
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma
R Andersen, M Donia, MCW Westergaard, M Pedersen, M Hansen, ...
Human vaccines & immunotherapeutics 11 (12), 2790-2795, 2015
452015
Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion
M Donia, M Hansen, SL Sendrup, TZ Iversen, E Ellebæk, MH Andersen, ...
Journal of Investigative Dermatology, 2012
442012
Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α
CH Riley, M Hansen, MK Brimnes, H Hans C., OW Bjerrum, P Straten, ...
European Journal of Haematology, 2014
402014
CCL22-specific T cells: modulating the immunosuppressive tumor microenvironment
E Martinenaite, S Munir Ahmad, M Hansen, Ö Met, MW Westergaard, ...
Oncoimmunology 5 (11), e1238541, 2016
392016
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: a randomized phase II study
P Kongsted, TH Borch, E Ellebaek, TZ Iversen, R Andersen, Ö Met, ...
Cytotherapy 19 (4), 500-513, 2017
382017
Differential CCR7 targeting in dendritic cells by three naturally occurring CC-chemokines
GM Hjortø, O Larsen, A Steen, V Daugvilaite, C Berg, S Fares, M Hansen, ...
Frontiers in immunology 7, 568, 2016
372016
Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy
M Hansen, GM Hjortø, M Donia, Ö Met, NB Larsen, MH Andersen, ...
Vaccine 31 (4), 639-646, 2013
372013
Cellular Based Cancer Vaccines: Type 1 Polarization of Dendritic Cells
M Hansen, O Met, IM Svane, MH Andersen
Current Medicinal Chemistry 19 (25), 4239-4246, 2012
332012
Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
C Nastasi, S Fredholm, A Willerslev-Olsen, M Hansen, CM Bonefeld, ...
Scientific reports 7 (1), 1-10, 2017
312017
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
S Munir Ahmad, E Martinenaite, M Hansen, N Junker, TH Borch, Ö Met, ...
Oncoimmunology 5 (8), e1202391, 2016
262016
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
TH Borch, L Engell-Noerregaard, T Zeeberg Iversen, E Ellebaek, Ö Met, ...
Oncoimmunology 5 (9), e1207842, 2016
252016
Interferon‐α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK 2V617F‐positive essential thrombocythemia …
CH Riley, MK Brimnes, M Hansen, MK Jensen, HC Hasselbalch, L Kjaer, ...
European journal of haematology 97 (1), 83-92, 2016
252016
Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
C Jensen, DH Madsen, M Hansen, H Schmidt, IM Svane, MA Karsdal, ...
Journal for immunotherapy of cancer 6 (1), 1-10, 2018
242018
Generating substrate bound functional chemokine gradients in vitro
GM Hjortø, M Hansen, NB Larsen, TN Kledal
Biomaterials 30 (29), 5305-5311, 2009
182009
PD-L1-specific T cells
SM Ahmad, TH Borch, M Hansen, MH Andersen
Cancer Immunology, Immunotherapy 65 (7), 797-804, 2016
152016
O sistema não pode efectuar a operação agora. Tente novamente mais tarde.
Artigos 1–20